Ubs Group Ag Artivion, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Artivion, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 241,628 shares of AORT stock, worth $6.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

241,628

Previous 186,028 29.89%

Holding current value

$6.83 Million

Previous $4.95 Million 40.43%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$25.41 - $30.11 $1.41 Million - $1.67 Million	55,600 Added 29.89%	241,628 $6.95 Million
Q3 2024 Nov 14, 2024	BUY	$24.33 - $28.46 $146,271 - $171,101	6,012 Added 3.34%	186,028 $4.95 Million
Q2 2024 Aug 13, 2024	SELL	$19.62 - $25.65 $121,055 - $158,260	-6,170 Reduced 3.31%	180,016 $4.62 Million
Q1 2024 May 13, 2024	SELL	$16.7 - $21.63 $137,724 - $178,382	-8,247 Reduced 4.24%	186,186 $3.94 Million
Q4 2023 Feb 09, 2024	BUY	$12.33 - $18.83 $355,017 - $542,172	28,793 Added 17.38%	194,433 $3.48 Million
Q3 2023 Nov 09, 2023	SELL	$14.82 - $17.52 $334,872 - $395,881	-22,596 Reduced 12.0%	165,640 $2.51 Million
Q2 2023 Aug 11, 2023	BUY	$12.78 - $17.23 $194,997 - $262,895	15,258 Added 8.82%	188,236 $3.24 Million
Q1 2023 May 12, 2023	SELL	$11.74 - $14.12 $67,868 - $81,627	-5,781 Reduced 3.23%	172,978 $2.27 Million
Q4 2022 Feb 08, 2023	BUY	$10.01 - $13.9 $45,505 - $63,189	4,546 Added 2.61%	178,759 $2.17 Million
Q3 2022 Nov 10, 2022	BUY	$13.31 - $23.25 $97,682 - $170,631	7,339 Added 4.4%	174,213 $2.41 Million
Q2 2022 Aug 10, 2022	BUY	$15.73 - $22.91 $124,849 - $181,836	7,937 Added 4.99%	166,874 $3.15 Million
Q1 2022 May 16, 2022	BUY	$16.95 - $21.74 $47,832 - $61,350	2,822 Added 1.81%	158,937 $3.4 Million
Q4 2021 Feb 14, 2022	BUY	$17.19 - $22.84 $630,116 - $837,223	36,656 Added 30.69%	156,115 $3.18 Million
Q3 2021 Nov 15, 2021	SELL	$22.29 - $28.7 $158,169 - $203,655	-7,096 Reduced 5.61%	119,459 $2.66 Million
Q2 2021 Aug 13, 2021	BUY	$22.32 - $32.07 $94,636 - $135,976	4,240 Added 3.47%	126,555 $3.59 Million
Q1 2021 May 12, 2021	BUY	$22.07 - $26.31 $1.18 Million - $1.4 Million	53,389 Added 77.46%	122,315 $2.76 Million
Q4 2020 Feb 11, 2021	BUY	$16.76 - $23.74 $130,593 - $184,982	7,792 Added 12.75%	68,926 $1.63 Million
Q3 2020 Nov 12, 2020	SELL	$16.35 - $21.4 $16,513 - $21,614	-1,010 Reduced 1.63%	61,134 $1.13 Million
Q2 2020 Jul 31, 2020	SELL	$16.34 - $25.24 $13,545 - $20,923	-829 Reduced 1.32%	62,144 $1.19 Million
Q1 2020 May 01, 2020	SELL	$14.66 - $30.57 $24,731 - $51,571	-1,687 Reduced 2.61%	62,973 $1.07 Million
Q4 2019 Feb 14, 2020	BUY	$22.45 - $27.09 $77,497 - $93,514	3,452 Added 5.64%	64,660 $1.75 Million
Q3 2019 Nov 14, 2019	SELL	$25.98 - $30.8 $163,414 - $193,732	-6,290 Reduced 9.32%	61,208 $1.66 Million
Q2 2019 Aug 14, 2019	BUY	$27.55 - $32.39 $226,461 - $266,245	8,220 Added 13.87%	67,498 $2.02 Million
Q1 2019 May 14, 2019	SELL	$25.85 - $30.47 $291,691 - $343,823	-11,284 Reduced 15.99%	59,278 $1.73 Million
Q4 2018 Feb 14, 2019	SELL	$25.76 - $34.03 $42,916 - $56,693	-1,666 Reduced 2.31%	70,562 $2 Million
Q3 2018 Nov 14, 2018	BUY	$28.6 - $35.75 $303,760 - $379,700	10,621 Added 17.24%	72,228 $2.54 Million
Q2 2018 Aug 14, 2018	BUY	$19.4 - $29.35 $97,019 - $146,779	5,001 Added 8.83%	61,607 $1.72 Million
Q1 2018 May 15, 2018	SELL	$16.85 - $22.1 $17,203 - $22,564	-1,021 Reduced 1.77%	56,606 $1.14 Million
Q4 2017 Feb 14, 2018	BUY	$18.65 - $23.85 $148,621 - $190,060	7,969 Added 16.05%	57,627 $1.1 Million
Q3 2017 Nov 14, 2017	SELL	$18.85 - $23.05 $11,818 - $14,452	-627 Reduced 1.25%	49,658 $1.13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,983 Added 6.31%	50,285 $1 Million
Q1 2017 Nov 14, 2017	BUY	N/A	47,302	47,302 $787,000

Others Institutions Holding AORT

# of Institutions

176

Shares Held

37.1M

Call Options Held

29.9K

Put Options Held

2.3K

View Full List

About ARTIVION, INC.

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.14B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

More about AORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account